Business Context and Reporting Period
Company: American International Group, Inc. (AIG)
Filing Type: Form 8-K (Current Report)
Date of Report: May 20, 2008
Event: Closing of a debt issuance and execution of a Replacement Capital Covenant.
Key Financial Metrics
This filing reports a specific capital transaction rather than periodic financial performance metrics (revenue, profit, cash flow, or margins).
- Debt Issuance: $4,000,000,000 of 8.175% Series A-6 Junior Subordinated Debentures.
- Offering Method: Rule 144A and Regulation S under the Securities Act of 1933.
- Related Instrument: 6.25% Notes due 2036 (CUSIP No. 026874AZ0).
Material Changes
The primary material change is the increase in long-term debt obligations by $4 billion. Additionally, AIG has entered into a contractual restriction regarding the repayment of this new debt.
Guidance, Outlook, and Covenants
Replacement Capital Covenant (RCC): In connection with the debt closing, AIG agreed to a covenant for the benefit of holders of its 6.25% Notes due 2036.
- Restriction: AIG and its subsidiaries are prohibited from repaying, redeeming, or purchasing the Series A-6 Junior Subordinated Debentures prior to May 15, 2068.
- Exception: Repayment is permitted only if AIG receives qualifying proceeds from the sale of certain replacement capital securities as defined in the RCC.
Management Commentary/Risks: The filing text does not provide general management commentary, forward-looking guidance, or a discussion of risks beyond the specific covenant terms.
Investor Verification Checklist
- Verify the terms of the Replacement Capital Covenant (Exhibit 99.1) to understand the specific definition of "qualifying proceeds" required to redeem the debt early.
- Confirm the impact of the $4 billion debt issuance on AIG's overall leverage ratios and liquidity position.
- Review the interest rate environment relative to the 8.175% coupon rate of the new debentures.
- Check for any subsequent filings regarding the sale of replacement capital securities referenced in the covenant.